|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$69,699.60 |
3.29% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$61,976.55 |
2.93% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$53,254.59 |
2.52% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$50,128.81 |
2.37% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$48,083.31 |
2.27% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$48,080.01 |
2.27% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$46,831.46 |
2.21% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$46,461.80 |
2.20% |
| Waters Corporation |
WAT |
941848103 |
120 |
$46,078.80 |
2.18% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$45,441.99 |
2.15% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$44,948.66 |
2.12% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$44,722.80 |
2.11% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,503.02 |
2.10% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$44,342.20 |
2.10% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$44,087.53 |
2.08% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$43,904.06 |
2.08% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$44,038.36 |
2.08% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$43,843.92 |
2.07% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$43,527.37 |
2.06% |
| Steris Plc |
STE |
G8473T100 |
169 |
$43,174.43 |
2.04% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$42,084.24 |
1.99% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$41,866.96 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$41,785.90 |
1.98% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$41,040.72 |
1.94% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$41,092.72 |
1.94% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$40,804.34 |
1.93% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$40,621.08 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$40,403.88 |
1.91% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$40,185.04 |
1.90% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$40,132.18 |
1.90% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$39,750.68 |
1.88% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$39,095.97 |
1.85% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$38,792.18 |
1.83% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$38,459.43 |
1.82% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$38,424.45 |
1.82% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$38,599.08 |
1.82% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$38,207.28 |
1.81% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,222.59 |
1.81% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$37,859.78 |
1.79% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$37,817.41 |
1.79% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$37,642.68 |
1.78% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,597.33 |
1.78% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$37,474.18 |
1.77% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$36,452.81 |
1.72% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$36,175.32 |
1.71% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$35,732.76 |
1.69% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$35,688.62 |
1.69% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$35,779.38 |
1.69% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$35,068.10 |
1.66% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$31,881.16 |
1.51% |
| US Dollar |
$USD |
|
3,544 |
$3,543.81 |
0.17% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|